Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

  • Sort by Relevance to quickly find articles that most closely match your query.
1.

Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study.

Alberts CJ, Vos RA, Borgdorff H, Vermeulen W, van Bergen J, Bruisten SM, Geerlings SE, Snijder MB, van Houdt R, Morré SA, de Vries HJ, van de Wijgert JH, Prins M, Schim van der Loeff MF.

Sex Transm Infect. 2016 May 17. pii: sextrans-2015-052397. doi: 10.1136/sextrans-2015-052397. [Epub ahead of print]

PMID:
27188273
2.

Incorporating microbiota data into epidemiologic models: examples from vaginal microbiota research.

van de Wijgert JH, Jespers V.

Ann Epidemiol. 2016 May;26(5):360-5. doi: 10.1016/j.annepidem.2016.03.004. Epub 2016 Apr 1. Review.

PMID:
27130291
3.

A fruitful alliance: the synergy between Atopobium vaginae and Gardnerella vaginalis in bacterial vaginosis-associated biofilm.

Hardy L, Jespers V, Abdellati S, De Baetselier I, Mwambarangwe L, Musengamana V, van de Wijgert J, Vaneechoutte M, Crucitti T.

Sex Transm Infect. 2016 Mar 10. pii: sextrans-2015-052475. doi: 10.1136/sextrans-2015-052475. [Epub ahead of print]

4.

Unique Insights in the Cervicovaginal Lactobacillus iners and L. crispatus Proteomes and Their Associations with Microbiota Dysbiosis.

Borgdorff H, Armstrong SD, Tytgat HL, Xia D, Ndayisaba GF, Wastling JM, van de Wijgert JH.

PLoS One. 2016 Mar 10;11(3):e0150767. doi: 10.1371/journal.pone.0150767. eCollection 2016.

5.

Adolescent sexual health: time to invest in a healthy future generation.

Jespers V, Nöstlinger C, van de Wijgert J.

Sex Transm Infect. 2016 Jun;92(4):248-9. doi: 10.1136/sextrans-2015-052485. Epub 2016 Feb 16. No abstract available.

PMID:
26884550
6.

Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection.

Francis SC, Hou Y, Baisley K, van de Wijgert J, Watson-Jones D, Ao TT, Herrera C, Maganja K, Andreasen A, Kapiga S, Coulton GR, Hayes RJ, Shattock RJ.

PLoS One. 2016 Jan 27;11(1):e0143109. doi: 10.1371/journal.pone.0143109. eCollection 2016.

7.

A Multi-Country Cross-Sectional Study of Vaginal Carriage of Group B Streptococci (GBS) and Escherichia coli in Resource-Poor Settings: Prevalences and Risk Factors.

Cools P, Jespers V, Hardy L, Crucitti T, Delany-Moretlwe S, Mwaura M, Ndayisaba GF, van de Wijgert JH, Vaneechoutte M.

PLoS One. 2016 Jan 26;11(1):e0148052. doi: 10.1371/journal.pone.0148052. eCollection 2016.

8.

A DNA tool for early detection of vaginal dysbiosis in African women.

Jespers V, Crucitti T, van de Wijgert J, Vaneechoutte M, Delany-Moretlwe S, Mwaura M, Agabe S, Menten J.

Res Microbiol. 2016 Feb-Mar;167(2):133-41. doi: 10.1016/j.resmic.2015.10.006. Epub 2015 Nov 11.

PMID:
26577657
9.

Evaluation of an enzymatic Chlamydia trachomatis point-of-care rapid assay in Rwanda: the BioChekSwab Rapid Test.

De Baetselier I, Mwambarangwe L, Cuylaerts V, Musengamana V, Agaba S, Kestelyn E, van de Wijgert J, Crucitti T.

Sex Transm Infect. 2016 Sep;92(6):430-2. doi: 10.1136/sextrans-2015-052202. Epub 2015 Oct 16.

PMID:
26474600
10.

Corrections. Factors affecting transmission of mucosal human papillomavirus.

Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH.

Lancet Infect Dis. 2015 Oct;15(10):1130. doi: 10.1016/S1473-3099(15)00299-6. Epub 2015 Aug 28. No abstract available.

PMID:
26461939
11.

Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply.

Jones HE, van de Wijgert JH.

Lancet HIV. 2015 Sep;2(9):e367. doi: 10.1016/S2352-3018(15)00156-3. Epub 2015 Aug 26. No abstract available.

PMID:
26423549
12.

DMPA use and HIV acquisition: time to switch to NET-EN?

Jones HE, van de Wijgert JH.

Lancet HIV. 2015 Jul;2(7):e263-4. doi: 10.1016/S2352-3018(15)00076-4. Epub 2015 May 27. No abstract available.

PMID:
26423248
13.

Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier.

Borgdorff H, Gautam R, Armstrong SD, Xia D, Ndayisaba GF, van Teijlingen NH, Geijtenbeek TB, Wastling JM, van de Wijgert JH.

Mucosal Immunol. 2016 May;9(3):621-33. doi: 10.1038/mi.2015.86. Epub 2015 Sep 9.

PMID:
26349657
14.

Combination Antiretroviral Therapy for HIV in Rwandan Adults: Clinical Outcomes and Impact on Reproductive Health up to 24 Months.

Asiimwe-Kateera B, Veldhuijzen N, Balinda JP, Rusine J, Eagle S, Vyankandondera J, Mugabekazi J, Ondoa P, Boer K, Asiimwe A, Lange J, Reiss P, van de Wijgert J.

AIDS Res Treat. 2015;2015:740212. doi: 10.1155/2015/740212. Epub 2015 Jul 16.

15.

Twelve-Month Antiretroviral Therapy Suppresses Plasma and Genital Viral Loads but Fails to Alter Genital Levels of Cytokines, in a Cohort of HIV-Infected Rwandan Women.

Ondoa P, Gautam R, Rusine J, Lutter R, Jurriaans S, Kootstra N, Karita E, van de Wijgert J.

PLoS One. 2015 May 26;10(5):e0127201. doi: 10.1371/journal.pone.0127201. eCollection 2015.

16.

Correlates of the molecular vaginal microbiota composition of African women.

Gautam R, Borgdorff H, Jespers V, Francis SC, Verhelst R, Mwaura M, Delany-Moretlwe S, Ndayisaba G, Kyongo JK, Hardy L, Menten J, Crucitti T, Tsivtsivadze E, Schuren F, van de Wijgert JH; Vaginal Biomarkers Study Group.

BMC Infect Dis. 2015 Feb 21;15:86. doi: 10.1186/s12879-015-0831-1.

17.

The ring plus project: safety and acceptability of vaginal rings that protect women from unintended pregnancy.

Schurmans C, De Baetselier I, Kestelyn E, Jespers V, Delvaux T, Agaba SK, van Loen H, Menten J, van de Wijgert J, Crucitti T; RING PLUS study group.

BMC Public Health. 2015 Apr 10;15:348. doi: 10.1186/s12889-015-1680-y.

18.

The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women.

Jespers V, van de Wijgert J, Cools P, Verhelst R, Verstraelen H, Delany-Moretlwe S, Mwaura M, Ndayisaba GF, Mandaliya K, Menten J, Hardy L, Crucitti T; Vaginal Biomarkers Study Group.

BMC Infect Dis. 2015 Mar 4;15:115. doi: 10.1186/s12879-015-0825-z.

19.

Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.

Kyongo JK, Crucitti T, Menten J, Hardy L, Cools P, Michiels J, Delany-Moretlwe S, Mwaura M, Ndayisaba G, Joseph S, Fichorova R, van de Wijgert J, Vanham G, Ariën KK, Jespers V.

Clin Vaccine Immunol. 2015 May;22(5):526-38. doi: 10.1128/CVI.00762-14. Epub 2015 Mar 11.

20.

The impact of hormonal contraception and pregnancy on sexually transmitted infections and on cervicovaginal microbiota in african sex workers.

Borgdorff H, Verwijs MC, Wit FW, Tsivtsivadze E, Ndayisaba GF, Verhelst R, Schuren FH, van de Wijgert JH.

Sex Transm Dis. 2015 Mar;42(3):143-52. doi: 10.1097/OLQ.0000000000000245.

PMID:
25668647
Items per page

Supplemental Content

Loading ...
Write to the Help Desk